logo

Arcturus Therapeutics Holdings Inc (ARCT) Stock: Uncovering a 52-Week Range and Trading Volume

HCCC Stock

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Arcturus Therapeutics Holdings Inc’s current trading price is -24.38% away from its 52-week high, while its distance from the 52-week low is 126.61%. The stock’s price range over this period has fluctuated between $14.62 and $43.81. The company, operating within the financial sector, had a trading volume of approximately 0.59 million for the day, which was noticeably higher than the average daily share volume of 0.42 million over the last 3 months.

Arcturus Therapeutics Holdings Inc saw a rather consistency, in terms of market performance. The company’s stock reached its highest point at $43.81 on 02/27/24, while the lowest price for the same duration was marked at $14.62 on 03/24/23.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Arcturus Therapeutics Holdings Inc (ARCT) has experienced a quarterly rise of 18.15% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 891.86M and boasts a workforce of 180 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 30.19, with a change in price of +13.80. Similarly, Arcturus Therapeutics Holdings Inc recorded 436,735 in trading volume during the last 100 days, posting a change of +71.39%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ARCT stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.

ARCT Stock Stochastic Average

Today, Arcturus Therapeutics Holdings Inc’s raw stochastic average for the past 50 days stands at 24.68%, indicating a rise from the raw stochastic average of the last 20 days, which was 1.02%. Moreover, the company’s Stochastic %K and %D values over the past 20 days were 13.52% and 24.25% respectively.

ARCT Stock Price Performance Analysis

The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a gain of 5.07%.However, over the last six months, we can see a weaker performance of 16.08%. Over the last 30 days, the price of ARCT has leaped by -13.25%. And in the last five days, it has fallen by -12.56%.